Medtronic Plc Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2018 Annual General Meeting of Shareholders held by Medtronic Plc on December 7, 2018. The filing was submitted on December 11, 2018. The meeting addressed the election of directors, the ratification of the independent auditor, and an advisory vote on executive compensation.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metrics.
Material Changes
No material financial changes are reported in this document. The primary events are the successful election of the board of directors and the ratification of the auditor.
Guidance, Outlook, and Voting Results
The filing details the outcomes of three shareholder proposals:
- Director Elections: All ten nominees were elected to the Board of Directors. Support ranged from 90.55% for Kendall J. Powell to 99.81% for Elizabeth Nabel, M.D.
- Auditor Ratification: Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2019 with 97.22% of votes cast in favor.
- Executive Compensation: Shareholders approved the named executive officer compensation on a non-binding advisory basis with 96.01% of votes cast in favor.
As of the record date (October 9, 2018), 1,348,097,639 ordinary shares were outstanding. A quorum was established with 1,167,256,445 shares present.
Investor Verification Checklist
- Verify the tenure of the newly elected directors, which extends until the 2019 Annual General Meeting.
- Confirm the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2019.
- Note the significant "Against" vote (9.45%) for director Kendall J. Powell compared to other nominees.
- Review the company's subsequent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.